Assistance Publique Hôpitaux de Paris

Hospital ship in New York, death of a teenager in Belgium, fears around Chinese growth … Update on the coronavirus

by

In France With. More than 3,000 deaths in hospitals, more than 5,000 patients in intensive care: the coronavirus epidemic continues to test French hospital services, in particular in Ile-de-France. 418 deaths have been recorded in the past twenty-four hours, according to the latest report released Monday evening. For the monitoring of other pathologies outside Covid-19, … Read more

Tocilizumab: the clinical trial of redacted, broken, but released AP-HP

by

A big slap. This is what has just received the researchers from the AP-HP in charge of conducting a clinical trial on Tocilizumab, a monoclonal antibody commonly used in the treatment of rheumatoid arthritis. On April 27, in a press release, the AP-HP welcomed the fact that in view of the first conclusions of the … Read more

Chloroquine: “In this case, the state did not play its role”

by

Professor Bernard Begaud, pharmacologist, former president of the University of Bordeaux, chaired the monitoring committee for clinical trials within the French Medicines Agency (ANSM) for more than fifteen years. He returns for Release on chloroquine, and points to the inconsistency and lack of coordination of the trials in progress. After three months of waiting, do … Read more

Concern rises over inflammation affecting children

by

The alert is worrying and the many pending questions will inevitably fuel anxiety. For several weeks, several medical teams in Europe have been worried about the growing appearance of serious inflammatory syndromes in children, some of which are associated with myocarditis (inflammation of the heart muscle). These teams wonder about the potential link with the … Read more

Covid-19: a promising treatment for serious patients

by

First glimmer of hope on the Cov2 treatment front. While 2,000 patients infected with Cov2 are in France engaged in clinical trials to test the possible benefit of existing drugs or molecules, the Assistance Publique-Hôpitaux de Paris (AP-HP) has just made public, for “ethical reasons “, the preliminary but promising results of a study on … Read more

Has La Poste hidden 24 million masks since the start of the epidemic?

by

Question asked by Kevin on 04/07/2020 Hello, You are referring to a press release from the SUD federation of postal and telecommunications activities, published on Monday. Entitled “Mind-blowing, the Post Office hides millions of masks“, The press release, taken up in particular by rebellious deputy Alexis Corbière, writes that the Post Office has 24 million … Read more

Covid-19: Agnès Buzyn, the flaws of a minister and a system

by

It was a month ago. An eternity since the Covid-19 turned time upside down. This Wednesday, March 4, the seven main candidates for mayor of Paris are debating for the first time on a television set. We are talking about social housing, garbage collection and greening, but already, the new coronavirus invites itself in the … Read more

Shortages extend to drugs

by

Faced with the unprecedented scale of the crisis and the influx of patients, stocks are running out. First those of protective masks. Then the reagents used in the Covid-19 diagnostic tests. And respirators, whose production is struggling to keep up with demand. Little by little, everything necessary for hospitalization and treatment of patients is running … Read more

Resuscitation drugs: “We fear a shortage of stocks”

by

Damien Roux, university professor and hospital practitioner of intensive resuscitation medicine, works in the medical and surgical resuscitation department of Louis-Mourier Hospital (AP-HP), located in Colombes, in the Hauts-de-Seine. As of last weekend, this doctor was responsible for reflecting – in collaboration with other colleagues from the Public Assistance taking care of Covid-19 patients – … Read more